These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19861311)

  • 1. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.
    Abrams MB; Dominguez C; Pernold K; Reger R; Wiesenfeld-Hallin Z; Olson L; Prockop D
    Restor Neurol Neurosci; 2009; 27(4):307-21. PubMed ID: 19738324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
    Tyndall A; Uccelli A
    Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
    Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
    Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
    Le Blanc K; Ringdén O
    Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
    Chou SH; Kuo TK; Liu M; Lee OK
    J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for clinical application.
    Sensebé L; Krampera M; Schrezenmeier H; Bourin P; Giordano R
    Vox Sang; 2010 Feb; 98(2):93-107. PubMed ID: 19663934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.